cough; sore throat; antigen home test, nasal swab which turned positive, repeated the test on 30Jan2022 which turned out to be slight positive; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), OROPHARYNGEAL PAIN (sore throat), SARS-COV-2 TEST POSITIVE (antigen home test, nasal swab which turned positive, repeated the test on 30Jan2022 which turned out to be slight positive) and HEADACHE (bad headache) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2022, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat), SARS-COV-2 TEST POSITIVE (antigen home test, nasal swab which turned positive, repeated the test on 30Jan2022 which turned out to be slight positive) and HEADACHE (bad headache). At the time of the report, COUGH (cough), OROPHARYNGEAL PAIN (sore throat), SARS-COV-2 TEST POSITIVE (antigen home test, nasal swab which turned positive, repeated the test on 30Jan2022 which turned out to be slight positive) and HEADACHE (bad headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2022, SARS-CoV-2 test: positive (Positive) Positive. On 30-Jan-2022, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medication were reported. No treatment details were reported. Patient received  flu shot on the same day of vaccination.  Company comment: This is a spontaneous case concerning a 20-year-old, female patient with no reported medical history, who experienced the unexpected, non-serious, AESI event of SARS-COV-2 test positive (antigen home test, nasal swab which turned positive), unexpected, non-serious events of cough and sore throat and expected, non-serious event of headache. The events cough, headache and sore throat occurred approximately one and a half month ago after the booster dose of mRNA-1273 vaccine administration. No reported treatment information. The outcome of the events headache and sore throat was resolved while the event cough was not resolved from the time of last observation. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-470284, MOD-2022-470217 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 20-year-old, female patient with no reported medical history, who experienced the unexpected, non-serious, AESI event of SARS-COV-2 test positive (antigen home test, nasal swab which turned positive), unexpected, non-serious events of cough and sore throat and expected, non-serious event of headache. The events cough, headache and sore throat occurred approximately one and a half month ago after the booster dose of mRNA-1273 vaccine administration. No reported treatment information. The outcome of the events headache and sore throat was resolved while the event cough was not resolved from the time of last observation. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.